Evidence map›Paper›PMID 34206651›Full record

ArticleMaterials (Basel, Switzerland)2021

Design and Development of Cellulosic Bionanocomposites from Forestry Waste Residues for 3D Printing Applications.

Maya Jacob John, Nokuzola Dyanti, Teboho Mokhena, Victor Agbakoba, Bruce Sithole

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Frontiers in 3D printing for biobased food packaging.Food science and biotechnology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maya Jacob JohnCentre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research (CSIR), Pretoria P.O. Box 395, South Africa.
Nokuzola DyantiCentre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research (CSIR), Pretoria P.O. Box 395, South Africa.
Teboho MokhenaCentre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research (CSIR), Pretoria P.O. Box 395, South Africa.
Victor AgbakobaCentre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research (CSIR), Pretoria P.O. Box 395, South Africa.
Bruce SitholeBiorefinery Industry Development Facility (BIDF), Council for Scientific and Industrial Research (CSIR), Durban P.O. Box 59081, South Africa.

Funding

Department of Science and Innovation, South Africa
6 · The paper itself

Abstract

This paper deals with the development of cellulose nanofibres (CNFs) reinforced biopolymers for use in packaging applications. Cellulose nanofibres were extracted from sawdust by a combination of chemical and mechanical treatments. The extracted cellulose nanofibres were chemically modified (fCNFs) and characterised by Fourier Transform Infrared Spectroscopy (FTIR). Bionanocomposites were prepared from biopolymers polylactic acid/polybutylene succinate (PLA/PBS) and cellulose nanofibres by compounding in a twin-screw extruder followed by injection moulding. The developed bionanocomposites were subjected to mechanical and thermal characterisation. As part of product development, CNF-biopolymer pellets were also extruded into filaments which were then 3D printed into prototypes. This work is a successful demonstration of conversion of waste residues into value-added products, which is aligned to the principles of circular economy and sustainable development.

Indexed as

3D printingbionanocompositesbiopolymercellulose nanofibres

Identifiers

PMID34206651
PMCPMC8269467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.